{
  "researcher": "Weaver, Donald F",
  "project": "Design and Development of Brain Permeant Indoleamine-2,3-Dioxygenase Inhibitors",
  "grant_date": "2017-09",
  "primary_institute": "Neuroinflammation and Neurodegenerative Diseases",
  "companies_analyzed": "Neurochem Inc., Treventis Corp.",
  "data": {
    "level3_series_a": [
      {
        "company_name": "Treventis Corp.",
        "funding_year": 2022,
        "funding_amount": "$2.97 million",
        "product_name": "small molecule anti-tau misfolding drug",
        "clinical_trial_year": null
      }
    ],
    "level4_series_bc": []
  },
  "scores": {
    "level3": 1,
    "level4": 0,
    "total": 1,
    "highest_level": 3
  }
}